AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering to unlock the potential of phytocannabinoids in designing medical therapies....
Read More
Michelle Hoiseth, Chief Data Officer for Parexel and Dr. Gunjan Bhardwaj, CEO Innoplexus discuss the importance of access to the latest COVID-19 data. The new COVID-19 Clearinghouse developed in partnership...
Read More
AI technologies are more widely used in the pharmaceutical industry today to enable for its extensive review of scientific and medical literature. Extensive data obtained through AI can support...
Read More
The World Health Organization announced a pandemic in April 2020. Artificial intelligence technologies have presented effective methods for accelerating research, monitoring spread of infection and to identify effective treatments to...
Read More
First discovered in December 2019 in China, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had spread worldwide. By April 2020 it was declared a pandemic by the World Health...
Read More
Leverage AI for the exploration, identification, and building of various direct and indirect connections between drugs, targets, pathways, and diseases. ...
Read More
